Measurement of translymphatic fluid absorption using technetium-99m human serum albumin diethylenetriamine pentaacetic acid in continuous ambulatory peritoneal dialysis patients.
We have established a new method of measuring translymphatic fluid absorption (TLA) using technetium-99m ((99m)Tc) human serum albumin diethylenetriamine pentaacetic acid ((99m)Tc-HSAD) that can be used commonly in clinical practice. This new method was applied in 13 continuous ambulatory peritoneal dialysis patients (11 males and two females) who had various peritoneal permeability and capacities for peritoneal transport of water. (99m)Tc-HSAD 740MBq was injected in 2 L of peritoneal dialysis fluid with 2.5% glucose, mixed well, and administered intraperitoneally. The fluid was drained extraperitoneally after 4 h and TLA was determined by the in vivo loss of (99m)Tc-HSAD. TLA was 1.41 +/- 1.11 mL/min (mean +/- SD; range, 0.27-3.69 mL/min). The estimated reduction rate by TLA in trans-peritoneally removed fluid ranged from 14.2 to 84.4%, indicating that TLA could have an extremely significant negative effect in some cases on total drainage volume. The present study, using new tracer (99m)Tc-HSAD, could confirm a large individual difference in TLA, indicating TLA as an important contributing factor for fluid-removal failure in continuous ambulatory peritoneal dialysis patients.
Terawaki
Hiroyuki
H
Division of Nephrology and Hypertension, Jikei University School of Medicine, Tokyo, Japan. terawaki@jikei.ac.jp
Nakayama
Masaaki
M
Seto
Kazuhiko
K
Yoshimura
Kazunobu
K
Hasegawa
Toshio
T
D000042:Absorption; D000368:Aged; D001826:Body Fluids / Q000378:metabolism*; D001834:Body Water / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D004369:Pentetic Acid; D010531:Peritoneal Dialysis, Continuous Ambulatory; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; D014462:Ultrafiltration
D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; D004369:Pentetic Acid